Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-02-23
2008-12-02
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S001690
Reexamination Certificate
active
07459425
ABSTRACT:
The present invention generally relates to non-ethylene diamine like compounds that prevent and/or delay carbamylation of peptides.
REFERENCES:
patent: 4605513 (1986-08-01), DiMarchi
patent: 2003/0045004 (2003-03-01), Barri et al.
Roberts et al. Ibuprofen, a putative anti-cataract drug, protects the lens against cyanate and galactose. Exp. Eye Res. vol. 50 (1990), pp. 157-164 (See document in related PCT/US2004/005374).
Lewis et al. Bendazac prevents cyanate binding to soluble lens proteins and cyanate-induced phase-separation opacities in vitro:a poss. mechanism by which bendazac could delay cataract. Exp. Eye Res.vol. 43 (1986) , pp. 973-979 (In PCT/US2004/00537).
Crompton et al. Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro:a poss. mechan. by which aspirin could prevent cataract. Exp. Eye Res.vol. 40 (1985),pp. 297-311 (In PCT/US2004/00537).
International Search Report, No. PCT/US2004/005374, Nov. 22, 2004.
Hasuike et al., “Carbamylated Hemoglobin as a Therapeutic marker in Hemodialysis,” Nephron, vol. 91, pp. 228-234 (2002).
Oimoni et al., “Carbamylation of Insulin and Its Biological Activity,” Nephron, vol. 46, pp. 63-66 (1987).
Black et al., “Ion Chromatographic Determination of Cyanate in Saline Gold Processing Samples,” Journal of Chromatography A, vol. 855, pp. 267-272 (1999).
Lippincott et al., “Carbamylation of Cysteine: A Potential Artifact in Peptide Mapping of Hemoglobins in the Presence of Urea,” Analytical Biochemistry, vol. 267, pp. 57-64 (1999).
Marier et. al., “Determination of Cyanate, and a Study of its Accumulation in Aqueous Solutions of Urea,”Anal. Biochem 7(1964) 304-314.
Stark, G.R., “Modification of Proteins with Cyanate,”Method In Enzymology 11(1967) 590-594.
Stark et. al., “Reactions of the Cyanate Present in Aqueous Urea with Amino Acids and Proteins,”J. Biol. Chem. 235(1960) 3177-3181.
Crompton et al., “Aspirin Prevents Carbamylation of Soluble Lens Proteins and Prevents Cyanate-induced Phase Separation Opacities In Vitro: A Possible Mechanism by which Aspirin could Prevent Cataract,”Exp. Eye Res. 40(1985) 297-311.
Ropp Phillip
Wan Min
Audet Maury
Dubberley F. Aaron
Hess Susan
N.V. Organon
Tsang Cecilia
LandOfFree
Reagents for protection of peptide/proteins carbamylation in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reagents for protection of peptide/proteins carbamylation in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents for protection of peptide/proteins carbamylation in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4020578